Company Analysis

Ainos, Inc. (AIMD)

Nasdaq: AIMD · Computer Peripheral Equipment, NEC · Houston, TX · filing with the SEC since 1996
Grade3.2
◀ Past 1.8● Present 2.2▶ Future 6.1
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

10 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Ainos, Inc.’s names, not what it holds today.

Patents granted
10
9 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and 2 in 2023
Applications published
8
since 2001, to Dec 31, 2025
Names they are printed under
4
a former name, its own name
By yearGrantedApplications published
'00'03'07'15'16'17'21'22'23'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology2
Measurement1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
AMARILLO BIOSCIENCES, INC a former name
US, as the owner printed on each patent
6 granted
2 published
AINOS, INC. its own name
US, as the owner printed on each patent
4 granted
0 published
AINOS, INC. its own name
named as the applicant on its applications, in US
0 granted
3 published
AMARILLO BIOSCIENCES, INC. a former name
named as the applicant on its applications, in US
0 granted
3 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Oct 1, 202412,105,006Gas detection system for gynecological disease detection and detection method using the sameMedical technologyAINOS, INC.
Dec 26, 2023D1,008,833Gas detection deviceAINOS, INC.
Apr 4, 202311,618,670Sensor with chamberMeasurementAINOS, INC.
Nov 15, 202211,497,855Smart drug injection deviceMedical technologyAINOS, INC.
Dec 12, 20179,839,672Treatment of thrombocytopenia using orally administered interferonPharmaceuticalsAMARILLO BIOSCIENCES, INC
Sep 5, 20179,750,786Treatment of thrombocytopenia using orally administered interferonPharmaceuticalsAMARILLO BIOSCIENCES, INC
Dec 27, 20169,526,694Treatment of thrombocytopenia using orally administered interferonPharmaceuticalsAMARILLO BIOSCIENCES, INC
Dec 2, 20036,656,920Composition and method for promoting oral healthPharmaceuticalsAMARILLO BIOSCIENCES, INC
Jan 14, 20036,506,377Interferon-alpha mediated upregulation of aquaporin expressionPharmaceuticalsAMARILLO BIOSCIENCES, INC
Mar 14, 20006,036,949Treatment of fibromyalgia with low doses of interferonPharmaceuticalsAMARILLO BIOSCIENCES, INC
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 12, 20242024/0408178LOW-DOSE INTERFERON COMPOSITION FOR CAT WITH LOW ADVERSE EFFECTS AND ITS USE AND METHODPharmaceuticalsAINOS, INC.
Oct 31, 20242024/0358290Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subjectMedical technologyAINOS, INC.
Sep 22, 20222022/0299418GAS DETECTION SYSTEM FOR GYNECOLOGICAL DISEASE DETECTION AND DETECTION METHOD USING THE SAMEMedical technologyAINOS, INC. · patent 12,105,006 granted from it
Apr 22, 20212021/0113777SMART DRUG INJECTION DEVICEMedical technologyAMARILLO BIOSCIENCES, INC · patent 11,497,855 granted from it
Dec 14, 20172017/0354715TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERONPharmaceuticalsAMARILLO BIOSCIENCES, INC. · patent 9,839,672 granted from it
Feb 16, 20172017/0042974TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERONPharmaceuticalsAMARILLO BIOSCIENCES, INC. · patent 9,750,786 granted from it
May 14, 20152015/0132261TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERONPharmaceuticalsAMARILLO BIOSCIENCES, INC. · patent 9,526,694 granted from it
Oct 11, 20072007/0237723TREATMENT OF COUGH WITH INTERFERONPharmaceuticalsAMARILLO BIOSCIENCES, INC
What it applied for, 2024 to 2025: Medical technology 1 · Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton AIMD · research, not advice